Eugene

[email protected]

LATEST

UK Gov’t, Gates Foundation Commit $50 Million to Combat Antibiotic Resistance
By

By
The UK Government’s Global Antimicrobial Resistance Innovation Fund (GAMRIF), a global innovation fund created to address antimicrobial resistance, and the Bill & Melinda Gates Foundation have partnered through CARB-X, a…

Lonza Expands Portfolio for In Vitro Testing
By

By
Lonza has added hepatic stellate cells, Kupffer cells, and liver-derived endothelial cells to its hepatocytes portfolio for testing of in vitro drug models. Lonza says hepatic non-parenchymal cells provide the…

Recipharm Plans To Increase Staffing In Preparation for Brexit
By

By
Recipharm, a Jordbro, Sweden-based contract development and manufacturing organization, has established a dedicated task force to manage the potential impact on its operations due to the UK’s withdrawal from the…

FDA OKs Third mAb To Be Manufactured at Samsung BioLogics’ New Plant
By

By
The US Food and Drug Administration (FDA) has licensed a third monoclonal antibody drug substance to be manufactured at Samsung BioLogics’ biomanufacturing facility in Incheon, South Korea. With this approval,…

Pfizer, Astellas Lead Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors, featuring news from Pfizer and Astellas Pharma. Editor’s Note: This article was updated on a continuous…

Novartis, US WorldMeds, Amgen Lead Drug Approval News
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Novartis and Amgen. Editor’s Note: This article was updated on a continuous basis for news announced…

CDMO Avara To Acquire Novartis’ Sterile Mfg Facility, Development Center
By

By
Avara Pharmaceutical Services, a Norwalk, Connecticut-headquartered contract development and manufacturing organization, has agreed to acquire Novartis’ sterile manufacturing facility for injectable medicines in Canada. The proposed acquisition of Novartis Technical…

WuXi Biologics To Invest $60 Million in Biologics Mfg Facility in Singapore
By

By
WuXi Biologics, part of WuXi AppTec, a Shanghai, China-headquartered contract service provider, plans to invest 80 million Singapore dollars (US $60 million) to establish a biologics manufacturing facility in Singapore.…

UK Government Prepares Brexit Scenarios for Pharma Regulation
By

By
The UK government has outlined various recommendations for pharmaceutical regulation and trade in the UK post the UK’s withdrawal from the European Union (EU) (i.e., Brexit). The recommendations, which depend…

Gilead Opens $11-Million Manufacturing Facility QC Lab
By

By
Gilead Sciences has opened a new EUR 9.5 million ($11-million) manufacturing facility quality-control (QC) laboratory in Carrigtwohill, County Cork, Ireland. The company said that during the last five years, manufacturing…